Clinical Trials Directory

Trials / Completed

CompletedNCT04285762

Supermicrosurgical LVA for Lymphedema Treatment

Supermicrosurgical Lymphatic Venous Anastomosis for Lymphedema Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
20 Years – 100 Years
Healthy volunteers
Not accepted

Summary

LVA orientations such as lymphaticovenous end-to-end (LVEEA), end-to-side (LVESA), and side-to-end (LVSEA) are commonly performed. Each orientation has its own advantages and disadvantages. The key factors affecting the type of anastomotic orientation are the sizes of the LVs and the RVs, and the relative distance between them. Most published literatures have focused on LVSEA2-9, which is considered to be the most efficient. With one anastomosis in LVSEA, the RV is able to drain both the antegrade and retrograde lymphatic flow. Nevertheless, how to determine the anastomotic orientation has remained ambiguous. In this study, we aimed to establish the basis of selecting the proper anastomotic orientation, based on the size and comparative size discrepancy between LV and RV. To the best of our knowledge, this is the first report to focus on this subject.

Conditions

Interventions

TypeNameDescription
OTHERLVEEAlymphaticovenous end-to-end
OTHERLVESAlymphaticovenous end-to-side
OTHERLVSEAlymphaticovenous side-to-end

Timeline

Start date
2018-11-01
Primary completion
2019-07-30
Completion
2019-12-31
First posted
2020-02-26
Last updated
2020-02-26

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04285762. Inclusion in this directory is not an endorsement.